238 related articles for article (PubMed ID: 23783773)
1. Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer's disease.
Easton A; Sankaranarayanan S; Tanghe A; Terwel D; Lin AX; Hoque N; Bourin C; Gu H; Ahlijanian M; Bristow L
Psychopharmacology (Berl); 2013 Nov; 230(2):279-89. PubMed ID: 23783773
[TBL] [Abstract][Full Text] [Related]
2. Donepezil attenuates Aβ-associated mitochondrial dysfunction and reduces mitochondrial Aβ accumulation in vivo and in vitro.
Ye CY; Lei Y; Tang XC; Zhang HY
Neuropharmacology; 2015 Aug; 95():29-36. PubMed ID: 25744714
[TBL] [Abstract][Full Text] [Related]
3. Effects of donepezil on amyloid-beta and synapse density in the Tg2576 mouse model of Alzheimer's disease.
Dong H; Yuede CM; Coughlan CA; Murphy KM; Csernansky JG
Brain Res; 2009 Dec; 1303():169-78. PubMed ID: 19799879
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
[TBL] [Abstract][Full Text] [Related]
5. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease.
Dong H; Csernansky CA; Martin MV; Bertchume A; Vallera D; Csernansky JG
Psychopharmacology (Berl); 2005 Aug; 181(1):145-52. PubMed ID: 15778881
[TBL] [Abstract][Full Text] [Related]
7. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
[TBL] [Abstract][Full Text] [Related]
8. In vivo 1H-magnetic resonance spectroscopy can detect metabolic changes in APP/PS1 mice after donepezil treatment.
Westman E; Spenger C; Oberg J; Reyer H; Pahnke J; Wahlund LO
BMC Neurosci; 2009 Apr; 10():33. PubMed ID: 19351388
[TBL] [Abstract][Full Text] [Related]
9. Donepezil improves learning and memory deficits in APP/PS1 mice by inhibition of microglial activation.
Guo HB; Cheng YF; Wu JG; Wang CM; Wang HT; Zhang C; Qiu ZK; Xu JP
Neuroscience; 2015 Apr; 290():530-42. PubMed ID: 25662507
[TBL] [Abstract][Full Text] [Related]
10. Amalaki Rasayana improved memory and neuronal metabolic activity in AbPP-PS1 mouse model of Alzheimer's disease.
Tiwari V; Saba K; Veeraiah P; Jose J; Lakhotia SC; Patel AB
J Biosci; 2017 Sep; 42(3):363-371. PubMed ID: 29358550
[TBL] [Abstract][Full Text] [Related]
11. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
[TBL] [Abstract][Full Text] [Related]
12. Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice.
Capsoni S; Giannotta S; Stebel M; Garcia AA; De Rosa R; Villetti G; Imbimbo BP; Pietra C; Cattaneo A
Am J Alzheimers Dis Other Demen; 2004; 19(3):153-60. PubMed ID: 15214201
[TBL] [Abstract][Full Text] [Related]
13. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Cai Z; Wang C; He W; Chen Y
Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
[TBL] [Abstract][Full Text] [Related]
14. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
[TBL] [Abstract][Full Text] [Related]
15. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of increasing donepezil in mild to moderate Alzheimer's disease patients who show a diminished response to 5 mg donepezil: a preliminary study.
Yatabe Y; Hashimoto M; Kaneda K; Honda K; Ogawa Y; Yuuki S; Ikeda M
Psychogeriatrics; 2013 Jun; 13(2):88-93. PubMed ID: 23909965
[TBL] [Abstract][Full Text] [Related]
17. Age-Related Decline in Brain and Hepatic Clearance of Amyloid-Beta is Rectified by the Cholinesterase Inhibitors Donepezil and Rivastigmine in Rats.
Mohamed LA; Qosa H; Kaddoumi A
ACS Chem Neurosci; 2015 May; 6(5):725-36. PubMed ID: 25782004
[TBL] [Abstract][Full Text] [Related]
18. Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer's disease.
Van Dam D; Coen K; De Deyn PP
Psychopharmacology (Berl); 2008 Mar; 197(1):37-43. PubMed ID: 18008065
[TBL] [Abstract][Full Text] [Related]
19. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing.
Hwang SH; Shin EJ; Shin TJ; Lee BH; Choi SH; Kang J; Kim HJ; Kwon SH; Jang CG; Lee JH; Kim HC; Nah SY
J Alzheimers Dis; 2012; 31(1):207-23. PubMed ID: 22543851
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25-35).
Tsunekawa H; Noda Y; Mouri A; Yoneda F; Nabeshima T
Behav Brain Res; 2008 Jul; 190(2):224-32. PubMed ID: 18420288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
